Ex-situ perfusion (ESP) is a promising method in preserving vascularized composite tissue allografts (VCAs) with potential to widen donor procurement to larger geographic areas. To optimize the method of preservation, we developed a small animal model to conduct biomolecular investigations. Twenty rat hind limbs (18.2 ± 1.3 g) were procured and connected to our custom-made ESP system. Perfusion pressure and flow parameters were measured with hourly blood gas analysis under near-normothermic (30-35˚C) conditions. Perfusate was prepared with swine hemoglobin (6-9 g/dL) and STEEN Solution. After 6 hours of perfusion, gastrocnemius muscles were evaluated for their histology and metabolomic profiling. Following 3 sets of experiments, perfusion was maintained at an average flow of 0.9 ± 0.24 mL/min and resulted in lactate levels of 3.78 ± 1.02 mmol/L. Metabolomic analysis revealed maintained cellular energy stores (total adenylates perfusion 0.698 ± 0.052 versus baseline 0.685 ± 0.091 umols/ug, p = 0.831), and histologic analysis revealed no evidence of barotrauma or myodegeneration. Rat hind limbs were viable after 6 hours of ESP on our miniaturized ESP system. This study is the first to document the ex-situ hind limb perfusion platform on a rodent model. These experimental findings have potential to guide future research to extend the viable duration of VCA preservation. ASAIO Journal 2019; 65:167-172.
Ex-situ perfusion (ESP) is an innovative technique aimed at
maintaining and improving the function of solid organs and vascularized composite allografts (VCAs) outside the body before transplantation. First reported in frog hearts by Alexis Carrel in the 1930's, this technology can extend preservation times by providing oxygenated and nutrient rich perfusate to tissue-preventing the progressive deterioration observed in cold storage preservation. 1 Over the last 10 years, ESP has improved clinical outcomes and reduced waiting lists. [2] [3] [4] This technology has not yet been used for VCAs at the clinical setting. Initial experimental studies using diluted blood at near-normothermic temperature successfully extended allograft survival up to 24 hours on swine and human forelimb allografts. [5] [6] [7] Despite this success in short-term survival, long-term functional outcome needs to be tested before its use in the clinical setting. For functional recovery, nerve regeneration needs to be evaluated in the long term. In swine allografts, this recovery may take up to 6 months, making the overall cost of experiments prohibitive. To circumvent these issues, we aimed to develop a VCA model on a small animal amenable to study long-term outcome as well as various hemodynamic and perfusion parameters. In this report, we described stepwise approach of development of a miniaturized ESP system for rodent hind limb allograft perfusion. We hope that our work helps other groups to establish similar systems to advance the field.
Materials and Methods
All animals received humane care in accordance with the National Institute of Health (NIH) Guide for the Care and Use of Laboratory Animals. The Institutional Animal Care and Use Committee approved all animal protocols. Inbred, male Lewis rats (275 ± 25 g) were used for all experiments. A total of 20 rats were divided into three parts of the experiment. In part 1, we aimed to establish an effective perfusion pressure and equally divided 10 rats into two groups. In group 1, the right femoral artery was cannulated with 1F catheter. In group 2, we cannulated the right common iliac artery with 22G catheter to test perfusion parameters. Following successful completion of the part 1, we focused on clearing waste products from the system in part 2. For that, we used five rats, and tested the efficacy of a hemofilter in clearing lactate and potassium. Finally, in part 3, we perfused five rat hind limbs for 6 hours and compared them with contralateral extremity control groups, in terms of muscle injury severity score, and metabolomics of gastrocnemius muscle.
Hind-Limb Procurement
All animals were injected with cefazolin (10 mg/kg) and anesthetized with Ketamine (30 mg/kg) and Xylazine (4 mg/ kg). General anesthesia sustained with inhaled Isoflurane (0.5-1.5%) blended into 100% oxygen. Donor animals were positioned supine. Oblique right anterior skin incisions were made parallel to the inguinal ligament and extended toward the abdominal cavity. The right femoral and iliac vessels were exposed and dissection extended to the aortic bifurcation, and all side branches were tied. The right common iliac artery was ligated and separated from its origin. Limbs were flushed with 5 cc of heparinized saline for 3 minutes using one of the two cannulas: rat femoral artery catheter (R-FC-R37, Braintree Scientific, Inc., MA) and 22G Angiocath (Becton, Dickinson and Company, New Jersey, NJ). Amputation of the hind limb Amputated limbs were attached to the ESP platform.
Perfusion System
The circuit was composed of a VCA chamber (Leak-proof Container, SE-560, Steeltainer, Quebec, CA), venous reservoir (LuerLok 30mL syringe, 302832, Becton Dickinson and Company, Franklin Lakes, NJ), peristaltic roller pump (Masterflex L/S peristaltic pump w/ easy-load 3 pump head, Pump: HV-07528, Pump head: HV-77800, Cole-Parmer, IL), hemofilter (Minntech Hemocor, HPH-Junior, Medtronic, Minneapolis, MN) with plasma outflow and inflow pumps (Alaris Infusion Pump, 7230, version 4.54, Alaris/Carefusion, CA), silicone membrane oxygenator (PDMSXA-1000, PermSelect, MI), custom-made coiled glass heat exchanger connected to a cardiopulmonary bypass heat regulator (TCM 400 MR, Terumo Sarns TCM II Heater Cooler, Sarns, Tokyo, Japan), and 22G cannula for arterial cannulation. All components were connected using 1/8 inch internal diameter PVC tubing (Nalgene 180 Clear Plastic PVC Tubing, ThermoFisher, 8000-9020, MA) and barbed tubing connectors (Harvard Apparatus, 72-1406, MA). All other parts were commercially available and can be sterilized using ethylene oxide (Figure 1) .
Perfusate Composition
The initial perfusate was primed by reconstituting STEEN Solution (~25 mL) with swine erythrocytes to target a hemoglobin of 6-9 g/dl. Before reconstitution, erythrocytes are washed and centrifuged to deplete them of platelets and leukocytes. Additionally, heparin (2,000 u), sodium bicarbonate (1 mEq), methylprednisolone (10 mg), cefazolin (5 mg), and calcium gluconate (15 mg) are added to the initial perfusate. Following VCA procurement, the hind limb was attached to the primed ESP system, and flow was initiated at 0.1 ml/min. Over the first 20 minutes, perfusion flow was incrementally increased up to 2.5 ml/min, and both the perfusate and ambient VCA chamber temperatures were adjusted from room temperature to 30-35ºC. Thereafter, the perfusion flow was adjusted to test the perfusion pressures. Percentage of O 2 in the oxygenator sweep is adjusted to maintain arterial pO 2 between 225 and 400 mm Hg, and 0.5 mEq sodium bicarbonate was administered to maintain an arterial base excess greater than ˗5.0 mmol/L.
Measured Variables
Perfusion parameters (vascular resistance, flow, pressure) were recorded continuously. Perfusate electrolytes, pH, lactate, pO 2 , and pCO 2 tested with hourly blood gas analysis under near-normothermic (30-35˚C) conditions. Weight gain also measured before and after perfusion. Oxygen consumption was calculated using a modified Fick equation using circuit flow, pre-and post-limb oxygen contents.
Metabolomics and Histologic Analysis
Following ESP, all hind limbs weighed and prepared for metabolomics and histologic analysis. A 100 mg sample of the gastrocnemius muscle was excised, flash frozen, and stored at ˗80ºC for metabolomic analysis. On the day of analysis, the sample underwent liquid chromatography-mass spectrometry detection including a liquid-liquid organic solvent extraction and separation on a 1 × 150 mm hydrophilic interaction liquid chromatography specific column in a 35-min cycle. All analytes and internal standards were measured by electrospray ionization on a liquid chromatography quadrupole time-of-flight mass spectrometer and reported as µM and normalized to wet tissue weight, volume, or cell proteins. 9 Additionally, samples of gastrocnemius muscles were formalin fixed, cross-sectioned, and stained via haematoxylin-eosin stain (H&E) to evaluate structural injury and apoptosis. Following staining, all muscle sections were digitally captured using a bright field microscope, and mean injury score was calculated using ImageScope software (v12.3.2.8013; Leica Microsystems GmbH, Wetzlar, Germany). To determine the extent of ischemia injury, we used the fourfold divided frame counting method. 
Statistical Analysis
Comparisons between groups was performed using the Student's t-test with GraphPad Prism 7.0 (La Jolla, CA). The value of p < 0.05 considered statistically significant. Data were expressed as means ± standard deviations.
Results

Part 1
We aimed to maintain the perfusion rate from 0.1 to 2 ml/ min. 11, 12 For that, we first used 1F cannula through femoral artery on 5 animals. When flow rate was adjusted to 1 ml/min, a gradual increase in perfusion pressure (above 150 mm Hg) was observed (physiologic pressure range, 50-90 mm Hg) in 30 minutes. Also, keeping flow rate at 0.9 ± 0.5 ml/min for 6 hours of ESP resulted in a high perfusion pressure (97.7 ± 16.7 mm Hg,), and barotrauma due to damage to capillary network, which in turn led to high lactate levels (> 19 mmol/L) and limb edema (> 35% weight gain).
In order to achieve physiologic pressure rates, we decided to use 22G cannula at the level of the common iliac artery. We tested this method on five animals. In this effort, perfusion pressure remained stable at 49.3 ± 19.4 mm Hg with a mean perfusion flow rate of 1 ± 0.3 ml/min for 6 hours (Figure 2) . This approach resulted in minimal shear stress and more laminar flow. In the end, we only had only 3.1 ± 0.4% g of weight gain after 6 hours of ESP. We were also able to reach the upper limit of the physiologic levels (2.5 ml/min) even in the near-normal pressure readings (100-150 mm Hg). However, gradual decrease in vascular resistance and perfusion pressure likely resulted from ongoing capillary injury along with moderate increases in lactate levels (10-15 mmol/L) and moderate edema (< 25% weight gain).
Part 2
We aimed to achieve electrolyte balance and to clear waste products. To accomplish this goal, we used continuous hemofiltration at a rate of 6 ml/hr. In that system, as plasma was siphoned, balanced crystalloid solution (Plasma-Lyte A, with 30 mEq/L sodium bicarbonate and 1,000 u/L heparin) was infused at an identical rate. In the end, perfusion flow rate was 0.7 ± 0.4 ml/min, and pressure was 51.65 ± 9.62 mm Hg. With continuous hemofiltration, lactate and potassium remained low in 4.3 ± 1.25 mmol/L, and 6.3 ± 1.17 mmol/L, respectively (Figure 3) . This modification allowed a more stable platform with better electrolyte balance and resulted in 6.74 ± 2.44% of weight gain after ESP.
Part 3
Using all parameters and methods established in the first two parts, we tested five more limbs and compared them with contralateral extremity. Controlled pressure of 33.74 ± 14.83 mm Hg resulted in 0.9 ± 0.24 ml/min flow rate. At the end of 6 hours of perfusion, lactate levels measured as only 3.78 ± 1.02 mmol/L (Figure 4) .
Qualitative histopathologic analysis of the gastrocnemius muscles in the perfusion group did not show any evidence for capillary barotrauma or myodegeneration ( Figure 5 ). Quantitative analysis of muscle injury severity score showed 62.87 ± 5.69% injury in contrast to 4.12 ± 3.12% of injury in control group (p < 0.005).
Metabolomic analysis of the samples showed sustained metabolic activity and preserved energy stores. There were no significant differences in high-energy phosphates compared with contralateral control muscle. Total adenylates were 0.685 ± 0.091 and 0.698 ± 0.052 (p = 0.831) umols/ ug in the control and end of perfusion samples, respectively. Baseline versus perfusion differences in adenosine triphosphate (ATP) was found as 0. 
Discussion
Similar to solid organ transplantation, the application of ESP to VCA transplantation will require thorough basic science and translational research. Previous investigators demonstrated promising results using pulsatile machine perfusion on VCA preservation using large animal models. 6, 13, 14 Although feasible, these investigations are expensive and labor intensive giving challenges associated with anesthesia and long-term housing of large animals. Compared with swine forelimb transplantation model, the use of rodents as organ donors and recipients are simple and cost-effective. They offer the possibility to conduct studies in a relatively rapid fashion. Additionally, allograft transplantations in rats within the same strain do not require immunosuppression. Also, rat sciatic nerve regeneration is well studied in the long term. 8 The perfusion system described here is modeled after previously published swine and human limb perfusion systems. 5, 7 Those systems maintained VCAs viability for 24 hours using hemoglobin-based, normothermic (30-35ºC) perfusion. Although normothermic perfusion offers several distinct advantages, the ideal perfusate and perfusion temperature are still unknown. The system we developed, however, can be modified, and used at temperatures from 10ºC to 42ºC. Moreover, effectiveness of different perfusion solutions can be tested in a cost-effective way. Our system also controls the flow by resistance with a roller pump providing with a more physiologic pulsatile flow into the system. As a result, our qualitative histology analysis performed under 10-20× of magnification, showed near normal muscle structure with no barotrauma. However, when quantitative muscle analysis was performed under 70× magnification, we observed that 60% of muscle cells have at least one type of lesion suggesting an injury compared with control group showing only 4%. In brief, while perfusion appeared adequate from metabolic standpoint as evidenced by preserved energy sources and lack of barotrauma, muscle cells continue to display damage. This is likely due to a variety of factors, including inadequate delivery of proteins regulating neurohumoral factors, inadequate membrane stabilization due to ionic imbalance, or simply related to mismatch between the blood donor and recipient species. Moving forward, we are currently working on testing rat blood/ plasma and plasma exchange protocols on our future studies.
One of the challenges in the perfusion system is the gradual accumulation of lactate and other metabolic byproducts during prolonged perfusion. Skeletal muscle is the major producer of lactic acid in the body. Unlike heart muscle, it may not use lactate as an energy source, and unlike liver, it may not clear lactate from the circulation. Consequently, higher lactate levels are expected, and gradual increase is an evidence for ongoing metabolic activity. In previous studies, investigators have used various methods, including frequent perfusate exchanges or administered bicarbonate, insulin, and glucose. Those approaches require continuous perfusate monitoring. 6, 14 In our system, we used a hemofiltration unit (molecular weight cutoff, 65,000 Daltons), which provided continuous filtration preventing steep changes in the concentration. [15] [16] [17] Although it can easily be lowered by increasing hemofiltration rate, we aimed to maintain a stable pH value. Therefore, we did not adjust filtration rate ambitiously unless significant acidosis or alkalosis was observed throughout the experiments. Also, the system described here was designed with a focus on clinical applicability and ease of scaling and has several additional advantages over other reported animal perfusion systems. First, the use of a commercially available membrane oxygenator is practical since, perfusionist and organ preservationists are familiar with their management. Second is the use or recirculating flow rather than single-pass flushing with a syringe pump. 18 Although feasible in small animal research, single-pass flushing is impractical when scaling to human extremities and associated with capillary barotrauma. Our system controls the flow by resistance with a roller pump providing more physiologic pulsatile flow into the system. Finally, for any ESP system to be used in VCAs, short-term viability should lead to long-term function. Rat hind limb transplantation is an ideal model for monitoring the long-term function on all components of VCAs although such assessment is beyond the scope of the current study. 19, 20 
Study Limitations
This study has three limitations. First, we used swine erythrocytes to perfuse rodent tissue. This method was chosen to minimize costs. Fresh rodent whole blood costs ~$5,000/L, whereas we have unlimited access to fresh swine blood due to ongoing experiments in our laboratory. To mitigate any confounding results caused by this xenoperfusion, erythrocytes were washed and separated from platelets and leukocytes. This purification process is similar to those used to create artificial oxygen carriers used in other studies. 5, 21, 22 The second limitation is that the system was only tested in near-normothermic conditions. Further modifications may be required to test perfusates at various temperature settings. Finally, procurement and reattachment of hind limb in rats require microsurgery, which can be performed with a 90-95% success rate by a well-trained surgeon.
Conclusion
In this study, we focused on developing a novel perfusion system that is simple and cost-efficient, to serve as a platform for continuous basic and translational research to advance the field of vascularized composite allotransplantation and replantation. Future applications of this platform may include reconditioning of marginal allografts, transplantation to assess long-term functional outcomes, and identifying vital components of circulation that might enable long-term perfusion and decrease the reperfusion injury.
